ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Pre-Transplant Assessment of AMR Risk by Novel Donor/recipient Non-HLA Variants

S. Pineda,1 T. Sigdel,1 J. Chen,1 A. Jackson,2 M. Sirota,1 M. Sarwal.1

1UCSF, San Francisco
2Johns Hopkins University, Baltimore.

Meeting: 2018 American Transplant Congress

Abstract number: 25

Keywords: Kidney transplantation, Rejection

Session Information

Session Name: Concurrent Session: Kidney Acute Antibody Mediated Rejection

Session Type: Concurrent Session

Date: Sunday, June 3, 2018

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:42pm-3:54pm

Location: Room Hall 4B

Transplant (tx) injury from antibody mediated (AMR) and T cell mediated (CMR) rejection, limits indefinite survival after HLA mismatched organ tx. AMR is incompletely diagnosed as donor/recipient (D/R) matching is only limited to the HLA locus and critical nHLA immunogenic antigens remain to be identified. We have developed an integrative computational approach leveraging D/R exome sequencing and gene expression to predict risk of post-tx AMR and CMR, by pre-tx assessment of a single blood sample from the D/R pair. Rigorous statistical analysis on 28 highly annotated D/R kidney tx pairs before tx, where the recipients developed biopsy confirmed rejection after tx, identified a significantly higher number of mismatched nHLA variants in AMR (p = 0.02), 123 variants associated with post-tx AMR risk (p < 0.001; Fischer's exact test), from which a subset of 65 variants identified recipients likely to develop AMR with very low error rate (random forest). These variants are functionally highly relevant to the rejection process as they relate to genes and/or eQTLs that are enriched in genes expressed in kidney and vascular endothelium and underlie the immunobiology of graft rejection. In addition to current D/R HLA mismatch evaluation, additional D/R mismatch nHLA analysis for the 65 variants, can enhance pre-tx D/R pair risk stratification for post-tx recipient AMR risk. This provides an AMR risk-score for each D/R pair even before engraftment of the tx organ, allowing for selective optimization for the D/R pair with lowest AMR and CMR risk, when multiple D/R pairs are available in the context of living donation. In the case of deceased donation, the AMR risk score for D/R pair can drive immunosuppression selection. This innovative study design is applicable in all solid organ tx, where the impact of mitigating AMR on graft survival may be greater, with considerable benefits on improving human morbidity and mortality and opens the door to precision immunosuppression delivery and extended tx survival.

CITATION INFORMATION: Pineda S., Sigdel T., Chen J., Jackson A., Sirota M., Sarwal M. Pre-Transplant Assessment of AMR Risk by Novel Donor/recipient Non-HLA Variants Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Pineda S, Sigdel T, Chen J, Jackson A, Sirota M, Sarwal M. Pre-Transplant Assessment of AMR Risk by Novel Donor/recipient Non-HLA Variants [abstract]. https://atcmeetingabstracts.com/abstract/pre-transplant-assessment-of-amr-risk-by-novel-donor-recipient-non-hla-variants/. Accessed May 16, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences